Aviron Message Board - Msg: 16879227

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron

AVIR 3.250

-0.6%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ChinuSFO who started this subject	1/8/2002 4:37:05 PM
From: sim1	of 645

Aviron Replies to Complete Response Letter MOUNTAIN VIEW, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Aviron (Nasdaq: AVIR - news) today submitted to the U.S. Food and Drug Administration (FDA) a formal reply to the complete response letter the FDA sent the Company on August 31, 2001 relating to its Biologics License Application for FluMist(TM), Aviron's investigational intranasal influenza vaccine. The Company's response provided additional information and clarification regarding clinical and manufacturing data, as requested by the FDA in the complete response letter.<snip>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next